- Home
- Our company
- Social impact
- Global health equity
- Improving access to care and services
Improving access to care and services
We collaborate with public and private sector organizations to expand access to care and services to improve global health.
Featured stories
Janssen, the Pharmaceutical Companies of Johnson & Johnson, Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children
Sub-Saharan African Ministries of Health Invited to Submit Expression of Interest to Participate in New EffortDonation Program to be Part of Broader Initiative to Raise Awareness and Action
Johnson & Johnson secures a top spot on the 2016 Access to Medicine Index
The index looks at companies that do the best job of providing access to medications in developing countries. Johnson & Johnson ranked #2—and here’s why.
More from Johnson & Johnson
Johnson & Johnson named to Fortune’s 2026 America’s Most Innovative Companies list
The company’s dedication to advancing solutions for the world’s most pressing health challenges has once again earned it a place on this annual ranking.
Meet a nurse who leads clinical trials to find innovative cancer therapies
Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.
These Johnson & Johnson leaders are breaking new ground in healthcare
Kimberly Lounds Foster and Carmen Canovas Vidal are part of a new wave of innovators bringing their expertise in STEM into the heart of healthcare.